// App-Quantinova.ai

TCT-69 : A Randomized Comparison of The Second Generation Biodegradable Polymer Sirolimus-eluting Stent (EXCEL-II) and The First Generation EXCEL-I stent in Patients with De novo Coronary Lesions: Clinical and Angiographic Outcomes of the CREDIT II Trial

Researchers

Presenter

  • Yaling Han

Principal Investigators

  • Yuejin Yang

  • Bo Xu

  • Xiaozeng Wang

  • Yong Sun

  • Zuyi Yuan

  • Haichang Wang

  • Jinghua Liu

  • Huiliang Liu

  • Genshan Ma

  • Geng Wang

  • Quanmin Jing

Medical Centers

  • Cardiovascular Institute and Fu Wai Hospital, Beijing, Beijing, China

  • Chinese Medical Association, Beijing, Beijing, China

  • Unknown, nanjing, China

  • Unknown, Shenyang, China

  • Beijing Hospital, Beijing, China

  • Xijing Hospital, The Fourth Military Medical University, Xi'an, China

  • Shenyang, Liaoning, China

  • The Second Aff Hospital of Zhejiang, Hangzhou, Zhejiang, China

  • Fu Wai Hospital, Beijing, Beijing, China

  • Northern hospital, Shenyang, Liaoning, China

Locations

  • China

Companies

  • Medtronic Plc

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

  • Excel II

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved